Tag "HCA"

The top ten articles of the first half of 2020

If the year 2020 were a football match, it would be halftime long ago. Reason enough to look back on the first half of 2020. Because a lot has happened in the first half of the year – including, of course, on the chemicals and pharmaceuticals blog. Since the beginning of the year, the team of authors and experts has again researched and written about some exciting topics related to automation. The following ten articles have aroused the greatest interest of the readers in the past six months.

Read More

The Future of High Content Analysis is 3D

Yokogawa and InSphero combine the power of advanced HCA (High Content Analysis) platform with multicellular 3D models for drug discovery. By the way: There’s a free webinar on June 18th on the subject. Registration is possible at the end of the blog article.

Read More

The Yokogawa Life Innovation Business is on the move

Yokogawa has long been committed to the sustainability goals formulated by the UN. In this context, the focus is on good health and well-being. Against this background, the aim is to strengthen the Life Science division in a targeted and sustainable manner in the future.
In order to drive this forward in Europe, Dr. Gerd Heimlich, has now joined Yokogawa as a new a new sales and market developer at Yokogawa Germany, has now assumed responsibility for the Life Innovation Business (LIB). He has worked in the medical device industry for the past 14 years. Prior to that, he was a life science researcher in the field of programmed cell death (apoptosis).
After a first visit to Yokogawa’s global LIB headquarters in Kanazawa, Japan, Dr. Heimlich was available for an interview. Among other things, he talked about the future direction of the Life Innovation Business and the changes that the near future will bring.

Read More